Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Hum Mol Genet ; 23(7): 1907-15, 2014 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-24256811

RESUMO

Cofactor disorders of mitochondrial energy metabolism are a heterogeneous group of diseases with a wide variety of clinical symptoms, particular metabolic profiles and variable enzymatic defects. Mutations in NFU1, BOLA3, LIAS and IBA57 have been identified in patients with deficient lipoic acid-dependent enzymatic activities and defects in the assembly and activity of the mitochondrial respiratory chain complexes. Here, we report a patient with an early onset fatal lactic acidosis presenting a biochemical phenotype compatible with a combined defect of pyruvate dehydrogenase (PDHC) and 2-ketoglutarate dehydrogenase (2-KGDH) activities, which suggested a deficiency in lipoic acid metabolism. Immunostaining analysis showed that lipoylated E2-PDH and E2-KGDH were extremely reduced in this patient. However, the absence of glycine elevation, the normal activity of the glycine cleavage system and the normal lipoylation of the H protein suggested a defect of lipoic acid transfer to particular proteins rather than a general impairment of lipoic acid biosynthesis as the potential cause of the disease. By analogy with yeast metabolism, we postulated LIPT1 as the altered candidate gene causing the disease. Sequence analysis of the human LIPT1 identified two heterozygous missense mutations (c.212C>T and c.292C>G), segregating in different alleles. Functional complementation experiments in patient's fibroblasts demonstrated that these mutations are disease-causing and that LIPT1 protein is required for lipoylation and activation of 2-ketoacid dehydrogenases in humans. These findings expand the spectrum of genetic defects associated with lipoic acid metabolism and provide the first evidence of a lipoic acid transfer defect in humans.


Assuntos
Aciltransferases/genética , Lipoilação/genética , Oxo-Ácido-Liases/genética , Acidose Láctica/genética , Acidose Láctica/mortalidade , Erros Inatos do Metabolismo dos Aminoácidos/genética , Animais , Células COS , Células Cultivadas , Chlorocebus aethiops , Metabolismo Energético/genética , Feminino , Humanos , Recém-Nascido , Complexo Cetoglutarato Desidrogenase/deficiência , Complexo Cetoglutarato Desidrogenase/genética , Ácidos Cetoglutáricos/metabolismo , Mitocôndrias/genética , Mitocôndrias/metabolismo , Mutação de Sentido Incorreto , Complexo Piruvato Desidrogenase/genética , Ácido Tióctico/metabolismo
2.
J Inherit Metab Dis ; 37(1): 53-62, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23774949

RESUMO

Primary coenzyme Q10 (CoQ10) deficiencies are associated with mutations in genes encoding enzymes important for its biosynthesis and patients are responsive to CoQ10 supplementation. Early treatment allows better prognosis of the disease and therefore, early diagnosis is desirable. The complex phenotype and genotype and the frequent secondary CoQ10 deficiencies make it difficult to achieve a definitive diagnosis by direct quantification of CoQ10. We developed a non-radioactive methodology for the quantification of CoQ10 biosynthesis in fibroblasts that allows the identification of primary deficiencies. Fibroblasts were incubated 72 h with 28 µmol/L (2)H3-mevalonate or 1.65 mmol/L (13)C6-p-hydroxybenzoate. The newly synthesized (2)H3- and (13)C6- labelled CoQ10 were analysed by high performance liquid chromatography-tandem mass spectrometry. The mean and the reference range for (13)C6-CoQ10 and (2)H3-CoQ10 biosynthesis were 0.97 (0.83-1.1) and 0.13 (0.09-0.17) nmol/Unit of citrate synthase, respectively. We validated the methodology through the study of one patient with COQ2 mutations and six patients with CoQ10 deficiency secondary to other inborn errors of metabolism. Afterwards we investigated 16 patients' fibroblasts and nine showed decreased CoQ10 biosynthesis. Therefore, the next step is to study the COQ genes in order to reach a definitive diagnosis in these nine patients. In the patients with normal rates the deficiency is probably secondary. In conclusion, we have developed a non-invasive non-radioactive method suitable for the detection of defects in CoQ10 biosynthesis, which offers a good tool for the stratification of patients with these treatable mitochondrial diseases.


Assuntos
Ataxia/diagnóstico , Ataxia/metabolismo , Fibroblastos/metabolismo , Doenças Mitocondriais/diagnóstico , Doenças Mitocondriais/metabolismo , Debilidade Muscular/diagnóstico , Debilidade Muscular/metabolismo , Mutação , Ubiquinona/análogos & derivados , Ubiquinona/deficiência , Linhagem Celular , Cromatografia Líquida de Alta Pressão , Citrato (si)-Sintase/metabolismo , Genótipo , Humanos , Técnicas de Diagnóstico Molecular , Fenótipo , Valores de Referência , Reprodutibilidade dos Testes , Pele/metabolismo , Espectrometria de Massas em Tandem , Fatores de Tempo , Ubiquinona/biossíntese , Ubiquinona/metabolismo
3.
J Inherit Metab Dis ; 36(5): 841-7, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23179554

RESUMO

Cofactor disorders of mitochondrial energy metabolism are a heterogeneous group of diseases with a wide variety of clinical symptoms, particular metabolic profiles and variable enzymatic defects. Mutations in NFU1 were recently identified in patients with fatal encephalopathy displaying a biochemical phenotype consistent with defects in lipoic acid-dependent enzymatic activities and respiratory chain complexes. This discovery highlighted the molecular function of NFU1 as an iron-sulfur(Fe-S) cluster protein necessary for lipoic acid biosynthesis and respiratory chain complexes activities. To understand the pathophysiological mechanisms underlying this disease we have characterized the protein expression profiles of patients carrying NFU1 mutations. Fibroblasts from patients with the p.Gly208Cys mutation showed complete absence of protein-bound lipoic acid and decreased SDHA and SDHB subunits of complex II. In contrast, subunits of other respiratory chain complexes were normal. Protein lipoylation was also decreased in muscle and liver but not in other tissues available (brain, kidney, lung) from NFU1 patients. Although levels of the respiratory chain subunits were unaltered in tissues, BN-PAGE showed an assembly defect for complex II in muscle, consistent with the low enzymatic activity of this complex. This study provides new insights into the molecular bases of NFU1 disease as well as into the regulation of NFU1 protein in human tissues. We demonstrate a ubiquitous expression of NFU1 protein and further suggest that defects in lipoic acid biosynthesis and complex II are the main molecular signature of this disease, particularly in patients carrying the p.Gly208Cys mutation.


Assuntos
Proteínas de Transporte/genética , Doenças Mitocondriais/genética , Mutação de Sentido Incorreto , Biossíntese de Proteínas/genética , Proteínas/genética , Transcriptoma/genética , Transporte de Elétrons/genética , Fibroblastos/metabolismo , Genótipo , Homozigoto , Humanos , Lactente , Mitocôndrias/genética , Mitocôndrias/metabolismo , Doenças Mitocondriais/metabolismo , Doenças Mitocondriais/patologia , Proteínas/metabolismo , Ácido Tióctico/genética , Ácido Tióctico/metabolismo
4.
Neurogenetics ; 13(3): 245-50, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22638997

RESUMO

The reported cases showed clinical, biochemical, histopathological, and molecular features lending support to the hypothesis of a pathogenic effect of the detected mutations. Case 1 was a neonatal presentation who showed multiple mitochondrial respiratory chain enzyme defects in muscle associated with a new homoplasmic m.5514A > G transition in the tRNA(Trp) gene. Case 2 was a late infantile presentation who also showed mitochondrial respiratory chain enzyme deficiencies in muscle together with a new m.1643A > G tRNA(Val) mutation in homoplasmy. Case 3 showed a MERRF phenotype presented in childhood associated with the once previously reported m.15923A > G mutation in heteroplasmy in all the tissues studied.


Assuntos
DNA Mitocondrial/genética , Síndrome MERRF/genética , Doenças Mitocondriais/genética , RNA de Transferência/genética , Sequência de Bases , Criança , Pré-Escolar , Transporte de Elétrons , Humanos , Recém-Nascido , Mitocôndrias/metabolismo , Dados de Sequência Molecular , Músculos/patologia , Mutação , Conformação de Ácido Nucleico , Fenótipo
5.
Antioxidants (Basel) ; 11(4)2022 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-35453428

RESUMO

The quantification of mitochondrial respiratory chain (MRC) enzymatic activities is essential for diagnosis of a wide range of mitochondrial diseases, ranging from inherited defects to secondary dysfunctions. MRC lesion is frequently linked to extended cell damage through the generation of proton leak or oxidative stress, threatening organ viability and patient health. However, the intrinsic challenge of a methodological setup and the high variability in measuring MRC enzymatic activities represents a major obstacle for comparative analysis amongst institutions. To improve experimental and statistical robustness, seven Spanish centers with extensive experience in mitochondrial research and diagnosis joined to standardize common protocols for spectrophotometric MRC enzymatic measurements using minimum amounts of sample. Herein, we present the detailed protocols, reference ranges, tips and troubleshooting methods for experimental and analytical setups in different sample preparations and tissues that will allow an international standardization of common protocols for the diagnosis of MRC defects. Methodological standardization is a crucial step to obtain comparable reference ranges and international standards for laboratory assays to set the path for further diagnosis and research in the field of mitochondrial diseases.

6.
Mitochondrion ; 26: 72-80, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26688339

RESUMO

Mutations in NFU1 were recently identified in patients with fatal encephalopathy. NFU1 is an iron-sulfur cluster protein necessary for the activity of the mitochondrial respiratory chain complexes I-II and the synthesis of lipoic acid. We report two NFU1 compound heterozygous individuals with normal complex I and lipoic acid-dependent enzymatic activities and low, but detectable, levels of lipoylated proteins. We demonstrated a leaky splicing regulation due to a splice site mutation (c.545+5G>A) that produces small amounts of wild type NFU1 mRNA that might result in enough protein to partially lipoylate and restore the activity of lipoic acid-dependent enzymes and the assembly and activity of complex I. These results allowed us to gain insights into the molecular basis underlying this disease and should be considered for the diagnosis of NFU1 patients.


Assuntos
Encefalopatias Metabólicas/diagnóstico por imagem , Encefalopatias Metabólicas/genética , Proteínas de Transporte/genética , Mutação , Sítios de Splice de RNA , Splicing de RNA , Encefalopatias Metabólicas/metabolismo , Proteínas de Transporte/metabolismo , Feminino , Humanos , Lactente , Lipoilação/genética , Masculino , Radiografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA